| Brian M Huber, MD | |
|
5314 Lincolnway E, Mishawaka, IN 46544-4249 | |
| (574) 584-2812 | |
| (574) 584-2813 |
| Full Name | Brian M Huber |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 5314 Lincolnway E, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538322805 | NPI | - | NPPES |
| 201038710 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01069683A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
Two out of five individuals delayed or missed medical care in the early phase of the pandemic-from March through mid-July 2020-according to a new survey from researchers at the Johns Hopkins Bloomberg School of Public Health.
A new center hosted at the University of Chicago - co-led by the largest medical imaging professional organizations in the country - will help tackle the ongoing COVID-19 pandemic by curating a massive database of medical images to help better understand and treat the disease.
Each year millions of children and adults in the world's poorest countries die from lack of access to medicine and health care. A new report from Rice University's Jones Graduate School of Business and the George W. Bush Institute offers a solution for improving distribution methods for health care information, products and services.
Six-month results from the DELUX registry demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon in more than 1000 patients were presented by Ralph Toelg, MD, Segeberger Heart Center Clinic, Germany, and Thomas Schmitz, MD, Elisabeth Hospital, Germany, at the EuroPCR 2012 congress in Paris last week.
› Verified 7 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
Two out of five individuals delayed or missed medical care in the early phase of the pandemic-from March through mid-July 2020-according to a new survey from researchers at the Johns Hopkins Bloomberg School of Public Health.
A new center hosted at the University of Chicago - co-led by the largest medical imaging professional organizations in the country - will help tackle the ongoing COVID-19 pandemic by curating a massive database of medical images to help better understand and treat the disease.
Each year millions of children and adults in the world's poorest countries die from lack of access to medicine and health care. A new report from Rice University's Jones Graduate School of Business and the George W. Bush Institute offers a solution for improving distribution methods for health care information, products and services.
Six-month results from the DELUX registry demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon in more than 1000 patients were presented by Ralph Toelg, MD, Segeberger Heart Center Clinic, Germany, and Thomas Schmitz, MD, Elisabeth Hospital, Germany, at the EuroPCR 2012 congress in Paris last week.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian M Huber, MD 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: (574) 647-2129 | Brian M Huber, MD 5314 Lincolnway E, Mishawaka, IN 46544-4249 Ph: (574) 584-2812 |
News Archive
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
Two out of five individuals delayed or missed medical care in the early phase of the pandemic-from March through mid-July 2020-according to a new survey from researchers at the Johns Hopkins Bloomberg School of Public Health.
A new center hosted at the University of Chicago - co-led by the largest medical imaging professional organizations in the country - will help tackle the ongoing COVID-19 pandemic by curating a massive database of medical images to help better understand and treat the disease.
Each year millions of children and adults in the world's poorest countries die from lack of access to medicine and health care. A new report from Rice University's Jones Graduate School of Business and the George W. Bush Institute offers a solution for improving distribution methods for health care information, products and services.
Six-month results from the DELUX registry demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon in more than 1000 patients were presented by Ralph Toelg, MD, Segeberger Heart Center Clinic, Germany, and Thomas Schmitz, MD, Elisabeth Hospital, Germany, at the EuroPCR 2012 congress in Paris last week.
› Verified 7 days ago
Theodore R Neumann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 406, Mishawaka, IN 46545 Phone: 574-335-6580 | |
Dr. Josephine Schimizzi, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1505 South Spring Street, Mishawaka, IN 46544 Phone: 574-255-0726 | |
Dale Dennis Deardorff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 420 W 4th St, Suite 180, Mishawaka, IN 46544 Phone: 574-247-3456 Fax: 574-247-3455 | |
James Mccarrey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 | |
Dr. Jack S. Bartoszek, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 615 Fulmer Rd, Mishawaka, IN 46544 Phone: 574-252-3085 Fax: 574-252-5906 | |
Dr. Lawrence R Curry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 E Mckinley Ave, Mishawaka, IN 46545 Phone: 574-256-2556 Fax: 574-258-4278 | |
Jennifer Anne Pennington, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 Fax: 574-254-7222 |